Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.cdc.gov › vaccines › phpPfizer COVID-19 Vaccine Summary | Vaccines & Immunizations | CDC

   www.cdc.gov › vaccines › php

   • Zapisane w pamięci cache

   28 sie 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).

2. www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-fullPfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S....

   www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-full

   • Zapisane w pamięci cache

   11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older; It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:

3. www.fda.gov › pfizer-biontech-covid-19-vaccinePfizer-BioNTech COVID-19 Vaccine | FDA

   www.fda.gov › pfizer-biontech-covid-19-vaccine

   • Zapisane w pamięci cache

   11 wrz 2023 · Translations of the Fact Sheet for Recipients and Caregivers. 09/11/2023. Regulated Product (s) Health Topic (s) Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) Authorized For...

4. www.fda.gov › news-events › press-announcementsFDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to...

   www.fda.gov › news-events › press-announcements

   • Zapisane w pamięci cache

   22 sie 2024 · Individuals 5 years through 11 years of age regardless of previous vaccination are eligible to receive a single dose of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines;...

5. www.pfizer.com › pfizer-and-biontech-announce-omicron-adapted-covid-19Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine ...

   www.pfizer.com › pfizer-and-biontech-announce-omicron-adapted-covid-19

   • Zapisane w pamięci cache

   25 cze 2022 · Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase against Omicron.

6. www.ema.europa.eu › en › newsComirnaty and Spikevax: EMA recommendations on extra doses and...

   www.ema.europa.eu › en › news

   • Zapisane w pamięci cache

   4 paź 2021 · EMA’s human medicines committee (CHMP) has concluded that an extra dose of the COVID-19 vaccines Comirnaty (BioNTech/Pfizer) and Spikevax (Moderna) may be given to people with severely weakened immune systems, at least 28 days after their second dose.

7. www.factcheck.org › 2020 › 12A Guide to Pfizer/BioNTech’s COVID-19 Vaccine - FactCheck.org

   www.factcheck.org › 2020 › 12

   • Zapisane w pamięci cache

   19 kwi 2024 · Quick Summary. Vaccine name: BNT162b2, marketed as Comirnaty. Design type: mRNA. Population: Adults and children 12 years of age and older. Dose number: Originally 2, 21 days apart, with a...